Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2005 3
2006 3
2007 6
2008 4
2009 2
2010 3
2011 3
2012 1
2013 4
2014 3
2015 4
2016 3
2017 2
2018 2
2019 6
2020 4
2021 7
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence.
Xu L, Pierce JL, Sanchez A, Chen KS, Shukla AA, Fustino NJ, Stuart SH, Bagrodia A, Xiao X, Guo L, Krailo MD, Shaikh F, Billmire DF, Pashankar F, Bestrashniy J, Oosterhuis JW, Gillis AJM, Xie Y, Teot L, Mora J, Poynter JN, Rakheja D, Looijenga LHJ, Draper BW, Frazier AL, Amatruda JF. Xu L, et al. Among authors: gillis ajm. Nat Commun. 2023 May 6;14(1):2636. doi: 10.1038/s41467-023-38378-9. Nat Commun. 2023. PMID: 37149691 Free PMC article.
Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors.
Timmerman DM, Eleveld TF, Sriram S, Dorssers LCJ, Gillis AJM, Schmidtova S, Kalavska K, van de Werken HJG, Oing C, Honecker F, Mego M, Looijenga LHJ. Timmerman DM, et al. Among authors: gillis ajm. J Clin Oncol. 2022 Sep 10;40(26):3077-3087. doi: 10.1200/JCO.21.02809. Epub 2022 Apr 20. J Clin Oncol. 2022. PMID: 35442716 Free PMC article.
Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial.
Mego M, Rejlekova K, Svetlovska D, Miskovska V, Gillis AJM, De Angelis V, Kalavska K, Obertova J, Palacka P, Reckova M, Sycova-Mila Z, Pindak D, Chovanec M, Looijenga LHJ, Mardiak J. Mego M, et al. Among authors: gillis ajm. Eur Urol Open Sci. 2021 Sep 22;33:19-27. doi: 10.1016/j.euros.2021.09.002. eCollection 2021 Nov. Eur Urol Open Sci. 2021. PMID: 34738090 Free PMC article.
Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.
Lobo J, Leão R, Gillis AJM, van den Berg A, Anson-Cartwright L, Atenafu EG, Kuhathaas K, Chung P, Hansen A, Bedard PL, Jewett MAS, Warde P, O'Malley M, Sweet J, Looijenga LHJ, Hamilton RJ. Lobo J, et al. Among authors: gillis ajm. Eur Urol Oncol. 2021 Jun;4(3):483-491. doi: 10.1016/j.euo.2020.11.004. Epub 2020 Dec 4. Eur Urol Oncol. 2021. PMID: 33288479
64 results